UBS lowered the firm’s price target on Blend Labs (BLND) to $3.50 from $4 and keeps a Neutral rating on the shares. Blend continues to face a well-understood challenging mortgage backdrop and focus is shifting towards consumer banking, the analyst tells investors in a research note.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BLND: